Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Delayed recovery of myocardial blood flow after intracoronary stem cell administration.
Gyöngyösi M, Hemetsberger R, Wolbank S, Pichler V, Kaun C, Posa A, Petrasi Z, Petnehazy Ö, Hofer-Warbinek R, de Martin R, Gruber F, Benedek I, Benedek T, Kovacs I, Benedek I Jr, Plass CA, Charwat S, Maurer G. Gyöngyösi M, et al. Among authors: charwat s. Stem Cell Rev Rep. 2011 Sep;7(3):616-23. doi: 10.1007/s12015-010-9213-7. Stem Cell Rev Rep. 2011. PMID: 21153508
Hypoxia-inducible factor 1-alpha release after intracoronary versus intramyocardial stem cell therapy in myocardial infarction.
Gyöngyösi M, Hemetsberger R, Posa A, Charwat S, Pavo N, Petnehazy O, Petrasi Z, Pavo IJ, Hemetsberger H, Benedek I, Benedek T, Benedek I Jr, Kovacs I, Kaun C, Maurer G. Gyöngyösi M, et al. Among authors: charwat s. J Cardiovasc Transl Res. 2010 Apr;3(2):114-21. doi: 10.1007/s12265-009-9154-1. Epub 2009 Dec 23. J Cardiovasc Transl Res. 2010. PMID: 20560024
Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
Nyolczas N, Gyöngyösi M, Beran G, Dettke M, Graf S, Sochor H, Christ G, Edes I, Balogh L, Krause KT, Jaquet K, Kuck KH, Benedek I, Hintea T, Kiss R, Préda I, Kotevski V, Pejkov H, Dudek D, Heba G, Sylven C, Charwat S, Jacob R, Maurer G, Lang I, Glogar D. Nyolczas N, et al. Among authors: charwat s. Am Heart J. 2007 Feb;153(2):212.e1-7. doi: 10.1016/j.ahj.2006.10.027. Am Heart J. 2007. PMID: 17239678 Clinical Trial.
Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study.
Gyöngyösi M, Lang I, Dettke M, Beran G, Graf S, Sochor H, Nyolczas N, Charwat S, Hemetsberger R, Christ G, Edes I, Balogh L, Krause KT, Jaquet K, Kuck KH, Benedek I, Hintea T, Kiss R, Préda I, Kotevski V, Pejkov H, Zamini S, Khorsand A, Sodeck G, Kaider A, Maurer G, Glogar D. Gyöngyösi M, et al. Among authors: charwat s. Nat Clin Pract Cardiovasc Med. 2009 Jan;6(1):70-81. doi: 10.1038/ncpcardio1388. Epub 2008 Nov 11. Nat Clin Pract Cardiovasc Med. 2009. PMID: 19002124 Clinical Trial.
Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study.
Charwat S, Lang I, Dettke M, Graf S, Nyolczas N, Hemetsberger R, Zamini S, Khorsand A, Sochor H, Maurer G, Glogar D, Gyöngyösi M. Charwat S, et al. Thromb Haemost. 2010 Mar;103(3):564-71. doi: 10.1160/TH09-08-0520. Epub 2010 Jan 13. Thromb Haemost. 2010. PMID: 20076851 Clinical Trial.
Imaging the migration of therapeutically delivered cardiac stem cells.
Gyöngyösi M, Hemetsberger R, Wolbank S, Kaun C, Posa A, Marian T, Balkay L, Emri M, Galuska L, Mikecz P, Petrasi Z, Charwat S, Hemetsberger H, Blanco J, Maurer G. Gyöngyösi M, et al. Among authors: charwat s. JACC Cardiovasc Imaging. 2010 Jul;3(7):772-5. doi: 10.1016/j.jcmg.2010.04.012. JACC Cardiovasc Imaging. 2010. PMID: 20633856 Free article. No abstract available.
Matrix Metalloproteinase-2 Impairs Homing of Intracoronary Delivered Mesenchymal Stem Cells in a Porcine Reperfused Myocardial Infarction: Comparison With Intramyocardial Cell Delivery.
Zlabinger K, Lukovic D, Hemetsberger R, Gugerell A, Winkler J, Mandic L, Traxler D, Spannbauer A, Wolbank S, Zanoni G, Kaun C, Posa A, Gyenes A, Petrasi Z, Petnehazy Ö, Repa I, Hofer-Warbinek R, de Martin R, Gruber F, Charwat S, Huber K, Pavo N, Pavo IJ, Nyolczas N, Kraitchman DL, Gyöngyösi M. Zlabinger K, et al. Among authors: charwat s. Front Bioeng Biotechnol. 2018 Apr 4;6:35. doi: 10.3389/fbioe.2018.00035. eCollection 2018. Front Bioeng Biotechnol. 2018. PMID: 29670878 Free PMC article.
12 results